RxDoctor Payments Data

Morgan Goldizen

Family · Tyrone, PANPI 1134890494

Payments from drug & device makers

$2,011in general payments, 2019–2025

Across 112 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$352
  • GSK$351
  • Lilly USA, LLC$264
  • Pfizer$236
  • AstraZeneca$144
  • Exact Sciences$126
  • plus $538 from 13 others

What the payments were for

  • Food & beverage$2,011100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,011 in reported general payments places this provider in the 80th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$7,745
Medicare patients
64
Services billed
100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin95$100,058
OzempicSemaglutide73$70,168
EliquisApixaban51$48,014
MounjaroTirzepatide44$44,841
Trelegy ElliptaFluticasone/Umeclidin/Vilanter63$44,752
XareltoRivaroxaban35$23,698
FarxigaDapagliflozin Propanediol13$22,347
TrulicityDulaglutide19$19,642
JanuviaSitagliptin Phosphate25$16,459
Breo ElliptaFluticasone/Vilanterol17$7,004
TradjentaLinagliptin11$6,406
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,323
Atorvastatin Calcium383$4,345
Albuterol Sulfate HfaAlbuterol Sulfate112$3,622
Levothyroxine Sodium307$3,195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$352$70,16873 claims
Lilly USA, LLCMounjaro, Trulicity$264$64,48463 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$351$57,07991 claims
PfizerEliquis$236$48,01451 claims
AstraZenecaFarxiga$144$22,34713 claims
MerckJanuvia$32$16,45925 claims
AbbVieSynthroid$106$91717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,717 family providers in Pennsylvania.

Other family in Tyrone

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →